Dr. Reddy’s Q2 net dips 32% to ₹913 cr on lower revenue
Dr. Reddy’s Q2 net falls 32% to ₹913 cr amid softer North America generics, declining revenue, and ongoing product relaunch plans.
BTC-1.00%
ETH-0.86%
SOL-1.72%
XRP-2.16%
USDC+0.00%
GRAMTON-6.64%
KAN-66.29%
SUI-2.35%BTC-1.00%ETH-0.86%SOL-1.72%XRP-2.16%USDC+0.00%GRAMTON-6.64%KAN-66.29%SUI-2.35%BTC-1.00%ETH-0.86%SOL-1.72%XRP-2.16%USDC+0.00%GRAMTON-6.64%KAN-66.29%SUI-2.35%BTC-1.00%ETH-0.86%SOL-1.72%XRP-2.16%USDC+0.00%GRAMTON-6.64%KAN-66.29%SUI-2.35%
